Acta Scientific Orthopaedics (ISSN: 2581-8635)

Opinion Volume 6 Issue 10

Autologous Platelet-Rich Plasma: Is it the Best Choice to Treat Degenerative Pathologies in the Elderly?

Vicente Mirabet1*, Pilar Solves2 and Isabel Guillén3

1Cell and Tissue Bank, Centro de Transfusión de Valencia, Spain 2Service of Haematology. Hospital Universitario y Politécnico La Fe, Spain 3Department of Pharmacy, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera CEU, Spain

*Corresponding Author: Vicente Mirabet, Cell and Tissue Bank, Centro de Transfusión de Valencia, Spain.

Received: August 10, 2023; Published: September 15, 2023


Thousands of scientific articles related to the clinical use of platelet-rich plasma (PRP) are published worldwide every year; perhaps as many as PRP infiltrations are carried out daily in the health centers of our cities. A significant number of these studies and these infiltrations refer to the use of PRP to treat degenerative pathologies in elderly people, frequently, patients having a poor systemic condition, even with problems for blood drawing.


  1. López-Otín C., et al. “The hallmarks of aging”. Cell6 (2013): 1194-1217.v
  2. Campisi J. “Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors”. Cell 4 (2005): 513-522.
  3. Conboy IM., et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment”. Nature 7027 (2005): 760-764.
  4. World Health Organization. “Blood safety and availability”.
  5. Bottegoni C., et al. “Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study”. Therapeutic Advances in Musculoskeletal Disease2 (2016): 35-41.
  6. Schallmoser K., et al. “Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells”. Transfusion8 (2007): 1436-1446.
  7. Rebulla P., et al. Multicentre standardisation of a clinical grade procedure for the preparation of allogeneic platelet concentrates from umbilical cord blood”. Blood Transfusion1 (2016): 73-79.
  8. Samarkanova D., et al. “Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application”. Blood Transfusion3 (2020): 208-216.


Citation: Vicente Mirabet., et al. “Autologous Platelet-Rich Plasma: Is it the Best Choice to Treat Degenerative Pathologies in the Elderly?". Acta Scientific Orthopaedics 6.10 (2023): 28-29.


Copyright: © 2023 Vicente Mirabet., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US